Trials / Sponsors / Meirav Kedmi MD
Meirav Kedmi MD
Other Government · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Improving the Outcome of High-risk Aggressive B-cell Lymphoma Patients With Nivolumab Maintenance Therapy Lymphoma, B-Cell | Phase 2 | 2018-10-08 |
| Unknown | Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggres Diffuse Large B Cell Lymphoma, Primary Mediastinal (Thymic) Large B-cell Lymphoma, Transformed Indolent Lymphoma | Phase 2 | 2016-12-01 |